On Target with Dr Akila Viswanathan - Dr Ana Kiess and Radiopharmaceuticals
Johns Hopkins Kimmel Cancer Center Podcasts
Release Date: 10/22/2024
Cancer Matters with Dr Bill Nelson - Treating Prostate Cancer
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson and Dr Sam Denmeade discuss the growing array of treatments for patients with prostate cancer available at the Johns Hopkins Kimmel Cancer Center.
info_outline
Cancer Matters with Dr Bill Nelson - Sarcoma Pathology
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson talks to Dr John Gross, a surgical pathologist, about the diagnosis of sarcomas, tumors most commonly found in bones and soft tissue. Dr Gross recently published a paper in Modern Pathology on his team's discovery of a new type of soft tissue tumor. .
info_outline
Cancer Matters with Dr Bill Nelson - New Treatments for Pancreatic Cancer
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.
info_outline
Cancer Matters with Dr Bill Nelson - Microbiome Research
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson and Dr Cynthia Sears discuss the role of the microbiome on our overall health, how it impacts cancer risk and the crucial role of federal research funding in understanding these organisms.
info_outline
Cancer Matters with Dr Bill Nelson - KRAS Mutations
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.
info_outline
Cancer Matters with Dr Bill Nelson - PSMA Targeted Therapies
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson and Dr Michael Carducci discuss using Prostate-Specific Membrane Antigen (PSMA) targeted therapies to detect and treat prostate cancer.
info_outline
On Target with Dr Akila Viswanathan - Novel Paradigms for Advanced Prostate Cancer for Seminars in Radiation Oncology
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Akila Viswanathan speaks with Dr Sophia Kamran from Harvard Medical School and Dr Constantinos Zamboglou from the German Oncology Center about the latest edition of Seminars in Radiation Oncology focusing on new treatments for advanced prostate cancer.
info_outline
Cancer Matters with Dr Bill Nelson - Epidemiology
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson talks to Dr Elizabeth Platz about her research studying the causes of cancer over time in large groups and using data to assess future risk.
info_outline
Cancer Matters with Dr Bill Nelson - Early Detection of Cancers
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson and Dr Bert Vogelstein discuss the development of tools for the early detection of cancers, which will lead to better treatments with fewer long-term consequences for patients.
info_outline
Cancer Matters with Dr Bill Nelson - Cancer Risk
Johns Hopkins Kimmel Cancer Center Podcasts
Dr Bill Nelson speaks with Dr Kala Visvanathan about her research assessing breast cancer risk, why many people are developing cancers earlier in life, and the tools she is developing to find cancer sooner, when it can be treated more effectively.
info_outlineDr Akila Viswanathan begins a special series focusing on women in radiation oncology at Johns Hopkins in this edition of the On Target podcast. Today she speaks with Dr Ana Kiess about treating patients with prostate cancer and head and neck cancers, her research on the integration of radiopharmaceutical therapies, and the unique challenges women face in academic medicine while balancing leadership roles, research, and clinical responsibilities.
Radiopharmaceuticals are a specialized group of drugs containing radioisotopes that emit radiation. They are used primarily in nuclear medicine and oncology for diagnostic and therapeutic purposes. These treatments deliver targeted radiation doses directly to tumors, damaging the cancer cells’ DNA and preventing their growth and spread. Dr Kiess highlights the ongoing clinical trials and advancements in radiopharmaceutical therapies, which are opening new possibilities for cancer treatment, especially in cases of prostate cancer.
The discussion also emphasizes the collaborative environment at Johns Hopkins, where specialists from multiple disciplines work together to advance the field. Dr Kiess explains how this collaborative approach enhances research and patient care, allowing for the development of innovative treatment protocols that can more effectively target cancers.